Dr. Cervantes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3507 Jaime Zapata Memorial Hwy
Ste 5
Laredo, TX 78043Phone+1 956-726-9252Fax+1 956-753-3442
Education & Training
California Pacific Medical CenterResidency, Pediatrics, 1972 - 1974
Medical College of GeorgiaResidency, Pediatrics, 1970 - 1972
District of Columbia General HospitalResidency, Pediatrics, 1969 - 1970
Rutgers HealthInternship, Transitional Year, 1968 - 1969
Universidad Autonoma de Nuevo LeonClass of 1968
Certifications & Licensure
TX State Medical License 1989 - 2025- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 1420 citationsEuropean LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Michele Baccarani, Michael W. Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini
Blood. 2013-08-08 - 2515 citationsFive-year follow-up of patients receiving imatinib for chronic myeloid leukemiaBrian J. Druker, François Guilhot, Stephen G. O'Brien, Insa Gathmann, Hagop M. Kantarjian
The New England Journal of Medicine. 2006-12-07 - 219 citationsSIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.Ruben A. Mesa, Jean-Jacques Kiladjian, John Catalano, Timothy Devos, Miklos Egyed
Journal of Clinical Oncology. 2017-09-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
